We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+11.9%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$347M
AUM Growth
+$65.8M
(+23%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
13.71%
Top 10 Holdings %
Top 10 Hldgs %
20.54%
Holding
122
New
27
Increased
57
Reduced
22
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Green Dot
GDOT
|
+$7.18M |
| 2 |
AVNS
Avanos Medical
AVNS
|
+$5.36M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$5.26M |
| 4 |
INXN
Interxion Holding N.V.
INXN
|
+$4.9M |
| 5 |
HubSpot
HUBS
|
+$3.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMED
Amedisys
AMED
|
+$5.02M |
| 2 |
Fair Isaac
FICO
|
+$4.62M |
| 3 |
KMG
KMG Chemicals Inc
KMG
|
+$4.35M |
| 4 |
STMP
Stamps.com, Inc.
STMP
|
+$4.13M |
| 5 |
Heartland Express
HTLD
|
+$3.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.34% |
| 2 | Financials | 16.69% |
| 3 | Technology | 12.16% |
| 4 | Industrials | 12.11% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMWD
76
DELISTED
American Woodmark
AMWD
| $2.15M | 0.62% |
27,389
+4,215
| +18% | +$360K |
|
|
KYNB
77
Kyntra Bio
KYNB
$29.4M
| $2.06M | 0.59% |
1,353
+209
| +18% | +$322K |
|
78
CONMED
CNMD
$1.47B
| $1.93M | 0.56% |
24,387
+3,941
| +19% | +$305K |
|
79
Acadia Pharmaceuticals
ACAD
$5.03B
| $1.93M | 0.56% |
+92,885
| New | +$1.46M |
|
80
Azenta
AZTA
$1.48B
| $1.81M | 0.52% |
51,740
+10,829
| +26% | +$356K |
|
81
Agios Pharmaceuticals
AGIO
$1.93B
| $1.77M | 0.51% |
22,938
+3,579
| +18% | +$288K |
|
82
Semtech
SMTC
$13B
| $1.72M | 0.5% |
+30,954
| New | +$1.62M |
|
83
Fate Therapeutics
FATE
$326M
| $1.61M | 0.46% |
98,993
+15,614
| +19% | +$185K |
|
|
PDCE
84
DELISTED
PDC Energy, Inc.
PDCE
| $1.5M | 0.43% |
30,644
+5,474
| +22% | +$303K |
|
85
Xencor
XNCR
$1.55B
| $1.47M | 0.42% |
37,598
-32,511
| -46% | -$1.33M |
|
|
AMRN
86
Amarin Corp
AMRN
$303M
| $1.31M | 0.38% |
+4,031
| New | +$304K |
|
|
SPPI
87
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.19M | 0.34% |
70,935
+4,437
| +7% | +$96K |
|
88
UroGen Pharma
URGN
$2.29B
| $860K | 0.25% |
+18,200
| New | +$846K |
|
89
Bio-Techne
TECH
$11.3B
| $451K | 0.13% |
8,848
-480
| -5% | -$21.3K |
|
90
Jack Henry & Associates
JKHY
$11.1B
| $316K | 0.09% |
1,971
-105
| -5% | -$15.4K |
|
|
SIVB
91
DELISTED
SVB Financial Group
SIVB
| $281K | 0.08% |
905
-46
| -5% | -$14.5K |
|
92
Broadridge
BR
$19B
| $278K | 0.08% |
2,109
-135
| -6% | -$17.1K |
|
93
Assured Guaranty
AGO
$3.34B
| $248K | 0.07% |
+5,862
| New | +$233K |
|
94
Alliance Resource Partners
ARLP
$3.17B
| $248K | 0.07% |
+12,137
| New | +$238K |
|
95
AllianceBernstein
AB
$3.47B
| $242K | 0.07% |
+7,958
| New | +$238K |
|
96
TransUnion
TRU
$15.3B
| $240K | 0.07% |
3,255
-175
| -5% | -$13K |
|
97
HEICO Corp Class A
HEI.A
$37.2B
| $230K | 0.07% |
+3,046
| New | +$210K |
|
98
West Pharmaceutical
WST
$24.9B
| $224K | 0.06% |
+1,817
| New | +$204K |
|
99
Target
TGT
$68B
| $223K | 0.06% |
+2,533
| New | +$211K |
|
100
Hexcel
HXL
$7.82B
| $219K | 0.06% |
3,259
-175
| -5% | -$11.9K |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Moody Aldrich Partners held 122 positions worth $347M, up 23% from $281M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Moody Aldrich Partners deployed $47.6M of net new capital in Q3 2018, opening 27 new positions and adding to 57 existing holdings. Its largest new stake was Green Dot: 86,347 shares worth $7.67M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Amedisys, an estimated $5.02M trimmed.
- Moody Aldrich Partners's largest Q3 2018 buy was Green Dot: 86,347 shares worth $7.67M.
- Moody Aldrich Partners added most to Interxion Holding N.V. in Q3 2018, an estimated $4.9M increase.
- Moody Aldrich Partners's biggest Q3 2018 reduction was Amedisys, cutting an estimated $5.02M.
- Moody Aldrich Partners fully exited Fair Isaac in Q3 2018, selling an estimated $4.62M.
- Moody Aldrich Partners's ten largest holdings make up 21% of its $347M portfolio in Q3 2018.
- Moody Aldrich Partners opened 27 new positions and closed 16 in Q3 2018.
- Moody Aldrich Partners's portfolio value rose 23% quarter-over-quarter to $347M.
Based on Moody Aldrich Partners's 13F filing for Q3 2018, filed 31 Oct 2018.